| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Space Flight | 11 | 2024 | 166 | 3.040 |
Why?
|
| Aerospace Medicine | 4 | 2022 | 39 | 0.940 |
Why?
|
| Human Experimentation | 1 | 2023 | 32 | 0.810 |
Why?
|
| Research Subjects | 1 | 2023 | 51 | 0.790 |
Why?
|
| Cosmic Radiation | 1 | 2022 | 14 | 0.760 |
Why?
|
| Radiation Protection | 1 | 2022 | 48 | 0.740 |
Why?
|
| Radiation Exposure | 1 | 2022 | 42 | 0.730 |
Why?
|
| Head-Down Tilt | 5 | 2018 | 26 | 0.670 |
Why?
|
| Psychiatry | 1 | 2023 | 269 | 0.640 |
Why?
|
| Intracranial Pressure | 4 | 2018 | 200 | 0.630 |
Why?
|
| Astronauts | 5 | 2024 | 77 | 0.620 |
Why?
|
| Weightlessness | 4 | 2024 | 81 | 0.600 |
Why?
|
| Intracranial Hypertension | 2 | 2018 | 129 | 0.550 |
Why?
|
| Urologic Surgical Procedures | 1 | 2017 | 61 | 0.520 |
Why?
|
| Membrane Proteins | 12 | 2006 | 1564 | 0.520 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 1 | 2015 | 14 | 0.470 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2015 | 111 | 0.470 |
Why?
|
| Embryonic and Fetal Development | 3 | 1999 | 125 | 0.430 |
Why?
|
| Carbon Dioxide | 4 | 2018 | 275 | 0.400 |
Why?
|
| Brain | 5 | 2023 | 3037 | 0.360 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 394 | 0.360 |
Why?
|
| Proteins | 4 | 2001 | 1021 | 0.330 |
Why?
|
| Monitoring, Physiologic | 3 | 2024 | 372 | 0.270 |
Why?
|
| Receptors, Cell Surface | 4 | 2002 | 422 | 0.240 |
Why?
|
| Cerebrovascular Circulation | 2 | 2018 | 471 | 0.210 |
Why?
|
| United States National Aeronautics and Space Administration | 2 | 2020 | 20 | 0.200 |
Why?
|
| Moon | 1 | 2022 | 14 | 0.190 |
Why?
|
| Adaptation, Physiological | 1 | 2024 | 258 | 0.190 |
Why?
|
| Mars | 1 | 2021 | 2 | 0.170 |
Why?
|
| Proteinuria | 1 | 2001 | 105 | 0.170 |
Why?
|
| Unemployment | 1 | 2020 | 23 | 0.170 |
Why?
|
| Mental Health | 1 | 2023 | 365 | 0.160 |
Why?
|
| Endopeptidases | 5 | 2005 | 108 | 0.160 |
Why?
|
| Research Personnel | 1 | 2020 | 124 | 0.150 |
Why?
|
| Body Patterning | 1 | 1999 | 128 | 0.150 |
Why?
|
| Fetal Proteins | 1 | 1998 | 10 | 0.150 |
Why?
|
| Mice | 19 | 2008 | 17704 | 0.150 |
Why?
|
| Intraocular Pressure | 2 | 2017 | 127 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 1999 | 96 | 0.140 |
Why?
|
| Animals | 22 | 2022 | 33242 | 0.140 |
Why?
|
| Presenilin-2 | 9 | 2006 | 19 | 0.140 |
Why?
|
| Transcription Factors | 4 | 2002 | 2346 | 0.140 |
Why?
|
| Pupil | 1 | 2018 | 40 | 0.140 |
Why?
|
| Helminth Proteins | 1 | 1998 | 103 | 0.140 |
Why?
|
| Jugular Veins | 1 | 2018 | 73 | 0.140 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 1998 | 95 | 0.140 |
Why?
|
| Blood Volume | 1 | 2018 | 71 | 0.140 |
Why?
|
| Megakaryocytes | 1 | 1997 | 33 | 0.140 |
Why?
|
| Humans | 23 | 2024 | 127585 | 0.140 |
Why?
|
| Radiation-Protective Agents | 1 | 2017 | 17 | 0.130 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 315 | 0.130 |
Why?
|
| Hypercapnia | 1 | 2017 | 22 | 0.130 |
Why?
|
| Cognition | 2 | 2024 | 806 | 0.130 |
Why?
|
| Databases, Factual | 1 | 2022 | 1199 | 0.130 |
Why?
|
| Caenorhabditis elegans | 1 | 1998 | 234 | 0.130 |
Why?
|
| Myocardium | 2 | 2005 | 849 | 0.130 |
Why?
|
| Rest | 1 | 2017 | 63 | 0.130 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1997 | 220 | 0.130 |
Why?
|
| Neovascularization, Physiologic | 1 | 1997 | 200 | 0.120 |
Why?
|
| Urology | 1 | 2017 | 84 | 0.120 |
Why?
|
| Creatine Kinase | 1 | 1996 | 63 | 0.120 |
Why?
|
| Radiation Injuries | 1 | 2017 | 136 | 0.120 |
Why?
|
| Presenilin-1 | 8 | 2005 | 50 | 0.120 |
Why?
|
| Hematopoiesis | 1 | 1997 | 208 | 0.120 |
Why?
|
| Spinal Puncture | 1 | 2015 | 50 | 0.120 |
Why?
|
| Microbiota | 1 | 2021 | 427 | 0.120 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1996 | 147 | 0.120 |
Why?
|
| Signal Transduction | 6 | 2005 | 4490 | 0.110 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 669 | 0.110 |
Why?
|
| Environment | 1 | 2015 | 148 | 0.110 |
Why?
|
| Reference Standards | 1 | 2015 | 230 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2020 | 535 | 0.110 |
Why?
|
| Kidney | 1 | 2001 | 1284 | 0.110 |
Why?
|
| Aspartic Acid Endopeptidases | 5 | 2005 | 31 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1998 | 979 | 0.110 |
Why?
|
| ROC Curve | 1 | 2015 | 592 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 2 | 2001 | 1096 | 0.100 |
Why?
|
| Weightlessness Simulation | 3 | 2018 | 22 | 0.100 |
Why?
|
| Health Status | 1 | 2014 | 382 | 0.090 |
Why?
|
| Molecular Sequence Data | 4 | 2001 | 3592 | 0.090 |
Why?
|
| Cross-Over Studies | 3 | 2017 | 327 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 3 | 2001 | 1205 | 0.090 |
Why?
|
| Adult | 8 | 2024 | 30609 | 0.090 |
Why?
|
| Health Behavior | 1 | 2014 | 387 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1999 | 824 | 0.080 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1990 | 30 | 0.080 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1990 | 50 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 1996 | 965 | 0.080 |
Why?
|
| Mitosis | 1 | 1990 | 190 | 0.080 |
Why?
|
| Double-Blind Method | 3 | 2017 | 1602 | 0.080 |
Why?
|
| Acetylcysteine | 2 | 2017 | 79 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2002 | 348 | 0.070 |
Why?
|
| Thinness | 1 | 2008 | 69 | 0.070 |
Why?
|
| Base Sequence | 3 | 2001 | 2766 | 0.070 |
Why?
|
| Absorptiometry, Photon | 1 | 2008 | 195 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2002 | 2544 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2000 | 2539 | 0.070 |
Why?
|
| In Situ Hybridization | 2 | 1998 | 449 | 0.070 |
Why?
|
| DNA, Complementary | 3 | 2005 | 435 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2001 | 683 | 0.070 |
Why?
|
| Receptors, Notch | 4 | 2002 | 195 | 0.060 |
Why?
|
| Adiposity | 1 | 2008 | 205 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 3711 | 0.060 |
Why?
|
| Male | 9 | 2024 | 62935 | 0.060 |
Why?
|
| Glycoproteins | 1 | 1988 | 338 | 0.060 |
Why?
|
| Amyloid beta-Peptides | 2 | 2005 | 217 | 0.060 |
Why?
|
| Amyloid Precursor Protein Secretases | 5 | 2005 | 59 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2008 | 475 | 0.060 |
Why?
|
| Cell Line | 6 | 2005 | 2571 | 0.060 |
Why?
|
| Young Adult | 2 | 2018 | 9714 | 0.060 |
Why?
|
| Systole | 1 | 2005 | 195 | 0.060 |
Why?
|
| Receptor, Notch1 | 3 | 2002 | 75 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2015 | 6265 | 0.060 |
Why?
|
| Middle Aged | 4 | 2018 | 27867 | 0.050 |
Why?
|
| Databases as Topic | 1 | 2024 | 74 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 1990 | 2309 | 0.050 |
Why?
|
| Mice, Knockout | 7 | 2008 | 3731 | 0.050 |
Why?
|
| Chromosome Fragility | 1 | 2003 | 13 | 0.050 |
Why?
|
| BRCA2 Protein | 1 | 2003 | 51 | 0.050 |
Why?
|
| DNA Adducts | 1 | 2003 | 71 | 0.050 |
Why?
|
| Gene Targeting | 2 | 2001 | 169 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2024 | 256 | 0.050 |
Why?
|
| Chromosome Mapping | 2 | 1999 | 1053 | 0.050 |
Why?
|
| Blotting, Northern | 2 | 2001 | 235 | 0.050 |
Why?
|
| Time Factors | 4 | 2024 | 6172 | 0.050 |
Why?
|
| Cells, Cultured | 4 | 2005 | 2921 | 0.040 |
Why?
|
| Longevity | 1 | 2003 | 154 | 0.040 |
Why?
|
| Social Behavior | 1 | 2023 | 218 | 0.040 |
Why?
|
| Transfection | 4 | 2005 | 955 | 0.040 |
Why?
|
| Lens, Crystalline | 1 | 2001 | 101 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2003 | 512 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2000 | 39 | 0.040 |
Why?
|
| Female | 6 | 2024 | 68803 | 0.040 |
Why?
|
| Calcium | 1 | 2005 | 1031 | 0.040 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2020 | 33 | 0.040 |
Why?
|
| Exons | 1 | 2003 | 759 | 0.040 |
Why?
|
| Cataract | 1 | 2001 | 146 | 0.040 |
Why?
|
| Thrombospondins | 2 | 1990 | 14 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2000 | 170 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 2000 | 176 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2000 | 111 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2001 | 579 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2001 | 418 | 0.040 |
Why?
|
| Hybrid Cells | 1 | 1999 | 78 | 0.040 |
Why?
|
| Chromosome Banding | 1 | 1999 | 136 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2005 | 4516 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 1999 | 365 | 0.040 |
Why?
|
| Hemodynamics | 2 | 2018 | 826 | 0.040 |
Why?
|
| Expressed Sequence Tags | 1 | 1998 | 78 | 0.040 |
Why?
|
| Protein Sorting Signals | 1 | 1998 | 40 | 0.040 |
Why?
|
| Valsalva Maneuver | 1 | 2018 | 7 | 0.040 |
Why?
|
| Breath Holding | 1 | 2018 | 8 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 590 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 1998 | 62 | 0.040 |
Why?
|
| Transcription, Genetic | 3 | 2001 | 1381 | 0.040 |
Why?
|
| Cytosol | 1 | 1998 | 138 | 0.040 |
Why?
|
| Somites | 1 | 1997 | 8 | 0.030 |
Why?
|
| Nervous System | 1 | 1998 | 119 | 0.030 |
Why?
|
| Islets of Langerhans | 1 | 1998 | 146 | 0.030 |
Why?
|
| Gene Library | 1 | 1998 | 212 | 0.030 |
Why?
|
| Melanocytes | 1 | 1997 | 45 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2002 | 728 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 621 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2006 | 3274 | 0.030 |
Why?
|
| Blood Vessels | 1 | 1997 | 98 | 0.030 |
Why?
|
| Aged | 1 | 2015 | 20500 | 0.030 |
Why?
|
| Pentoxifylline | 1 | 2017 | 20 | 0.030 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2017 | 34 | 0.030 |
Why?
|
| Adolescent | 1 | 2015 | 20183 | 0.030 |
Why?
|
| Free Radical Scavengers | 1 | 2017 | 53 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1998 | 588 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1999 | 754 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 2017 | 110 | 0.030 |
Why?
|
| Cell Membrane | 3 | 2005 | 449 | 0.030 |
Why?
|
| Bed Rest | 1 | 2017 | 23 | 0.030 |
Why?
|
| Cerebral Veins | 1 | 2017 | 18 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 984 | 0.030 |
Why?
|
| Hydrodynamics | 1 | 2017 | 29 | 0.030 |
Why?
|
| Obesity | 1 | 2008 | 2338 | 0.030 |
Why?
|
| Cerebrospinal Fluid | 1 | 2017 | 96 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1996 | 59 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2017 | 130 | 0.030 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2017 | 135 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 1206 | 0.030 |
Why?
|
| DNA | 3 | 2005 | 1426 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2017 | 214 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 1141 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 214 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 1998 | 566 | 0.030 |
Why?
|
| Cell Division | 2 | 2002 | 718 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2000 | 1012 | 0.030 |
Why?
|
| Metformin | 1 | 2017 | 159 | 0.030 |
Why?
|
| Immunoprecipitation | 2 | 2006 | 187 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 293 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1996 | 396 | 0.030 |
Why?
|
| Curriculum | 1 | 2020 | 768 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2000 | 2281 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 784 | 0.030 |
Why?
|
| Behavioral Research | 1 | 2014 | 17 | 0.030 |
Why?
|
| Blastocyst | 2 | 2005 | 77 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1996 | 270 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2001 | 1775 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2018 | 944 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 2586 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 456 | 0.030 |
Why?
|
| Gene Expression | 1 | 1997 | 1494 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 655 | 0.020 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 795 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 1998 | 714 | 0.020 |
Why?
|
| United States | 2 | 2020 | 11427 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2005 | 1016 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 428 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 3717 | 0.020 |
Why?
|
| Neurons | 3 | 2005 | 1911 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2002 | 308 | 0.020 |
Why?
|
| Fibronectins | 1 | 1990 | 99 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 735 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2005 | 1598 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2005 | 1604 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2001 | 719 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2002 | 1232 | 0.020 |
Why?
|
| Mutation | 4 | 2005 | 5953 | 0.020 |
Why?
|
| Deoxyribonuclease BamHI | 1 | 1988 | 6 | 0.020 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1988 | 8 | 0.020 |
Why?
|
| Collagen | 1 | 1990 | 293 | 0.020 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1988 | 48 | 0.020 |
Why?
|
| Endonucleases | 1 | 1988 | 50 | 0.020 |
Why?
|
| Growth Hormone | 1 | 1988 | 125 | 0.020 |
Why?
|
| Protein Binding | 2 | 2002 | 1666 | 0.020 |
Why?
|
| Cattle | 1 | 1988 | 540 | 0.020 |
Why?
|
| Phenotype | 2 | 2008 | 4312 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2008 | 271 | 0.020 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2006 | 70 | 0.020 |
Why?
|
| Ionophores | 1 | 2005 | 9 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 2005 | 55 | 0.010 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2005 | 37 | 0.010 |
Why?
|
| Papillary Muscles | 1 | 2005 | 18 | 0.010 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2005 | 36 | 0.010 |
Why?
|
| Carbamates | 1 | 2005 | 55 | 0.010 |
Why?
|
| Dipeptides | 1 | 2005 | 64 | 0.010 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2005 | 146 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 426 | 0.010 |
Why?
|
| Alzheimer Disease | 2 | 2003 | 833 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2005 | 239 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2005 | 327 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 788 | 0.010 |
Why?
|
| Fibrosis | 1 | 2005 | 402 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 1092 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2006 | 351 | 0.010 |
Why?
|
| Affinity Labels | 1 | 2003 | 10 | 0.010 |
Why?
|
| Breeding | 1 | 2003 | 18 | 0.010 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2005 | 239 | 0.010 |
Why?
|
| Rad51 Recombinase | 1 | 2003 | 31 | 0.010 |
Why?
|
| Gamma Rays | 1 | 2003 | 41 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2003 | 50 | 0.010 |
Why?
|
| Genes, BRCA2 | 1 | 2003 | 48 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2003 | 156 | 0.010 |
Why?
|
| Mitomycin | 1 | 2003 | 48 | 0.010 |
Why?
|
| Binding Sites | 1 | 2005 | 1188 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2003 | 283 | 0.010 |
Why?
|
| Cell Extracts | 1 | 2002 | 14 | 0.010 |
Why?
|
| Leupeptins | 1 | 2002 | 21 | 0.010 |
Why?
|
| Genotype | 1 | 2008 | 2604 | 0.010 |
Why?
|
| Detergents | 1 | 2002 | 21 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2002 | 56 | 0.010 |
Why?
|
| Prosencephalon | 1 | 2002 | 36 | 0.010 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2001 | 11 | 0.010 |
Why?
|
| Fluorometry | 1 | 2002 | 25 | 0.010 |
Why?
|
| Osmosis | 1 | 2001 | 17 | 0.010 |
Why?
|
| Aquaporins | 1 | 2001 | 16 | 0.010 |
Why?
|
| Solubility | 1 | 2002 | 122 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2001 | 136 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2002 | 80 | 0.010 |
Why?
|
| Chimera | 1 | 2001 | 79 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2001 | 154 | 0.010 |
Why?
|
| Luciferases | 1 | 2001 | 127 | 0.010 |
Why?
|
| Retroviridae | 1 | 2002 | 182 | 0.010 |
Why?
|
| Etoposide | 1 | 2001 | 110 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 260 | 0.010 |
Why?
|
| Permeability | 1 | 2001 | 116 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 2002 | 93 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2889 | 0.010 |
Why?
|
| Lasers | 1 | 2001 | 109 | 0.010 |
Why?
|
| Alleles | 1 | 2006 | 1610 | 0.010 |
Why?
|
| Transcription Factor CHOP | 1 | 2000 | 4 | 0.010 |
Why?
|
| Optics and Photonics | 1 | 2001 | 99 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 2000 | 47 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2005 | 760 | 0.010 |
Why?
|
| Water | 1 | 2001 | 188 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 841 | 0.010 |
Why?
|
| Models, Biological | 1 | 2005 | 1376 | 0.010 |
Why?
|
| Ligands | 1 | 2001 | 478 | 0.010 |
Why?
|
| Eye Proteins | 1 | 2001 | 229 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 564 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2002 | 447 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2002 | 272 | 0.010 |
Why?
|
| DNA Damage | 1 | 2003 | 499 | 0.010 |
Why?
|
| Protein Folding | 1 | 2000 | 215 | 0.010 |
Why?
|
| Homozygote | 1 | 2001 | 541 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2000 | 202 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2002 | 589 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 1299 | 0.010 |
Why?
|
| Heterozygote | 1 | 2001 | 692 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2001 | 553 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2006 | 2405 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2002 | 834 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2000 | 826 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 4444 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2000 | 770 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2000 | 761 | 0.010 |
Why?
|
| Apoptosis | 1 | 2002 | 1826 | 0.010 |
Why?
|
| Disease Progression | 1 | 2001 | 2127 | 0.010 |
Why?
|
| Age Factors | 1 | 2001 | 2814 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 1893 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2002 | 1887 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2000 | 1509 | 0.010 |
Why?
|